Company: PTHS
Filing Date: 2025-05-09
Form Type: PREM14C
Source: 0001140361-25-018219
Chunk: 787

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-05-09
Form: PREM14C
Chunk 787
---
110,953.00     |     |                         |

E-16

TABLE OF CONTENTS

IN WITNESS WHEREOF , each of the undersigned, constituting the Requisite Majority, has executed this Written Consent of the Majority Stockholders in Lieu of a Special Meeting as of the date first above written.

| MDB MERCHANTS PARK LLC       |     |                    |
| By:                          |     | /s/ Michael Bodner |
| Name:                        |     | Michael Bodner     |
| Title:                       |     | Manager            |
| Number of Shares: 290,277.00 |     |                    |

E-17

TABLE OF CONTENTS

IN WITNESS WHEREOF , each of the undersigned, constituting the Requisite Majority, has executed this Written Consent of the Majority Stockholders in Lieu of a Special Meeting as of the date first above written.

| MOTIF PHARMACEUTICALS LTD.   |     |                   |
| By:                          |     | /s/ Zachary Klein |
| Name:                        |     | Zachary Klein     |
| Title:                       |     | Director          |
| Number of Shares: 483,406.00 |     |                   |

E-18

TABLE OF CONTENTS

IN WITNESS WHEREOF , each of the undersigned, constituting the Requisite Majority, has executed this Written Consent of the Majority Stockholders in Lieu of a Special Meeting as of the date first above written.

| SARGEANT CAPITAL            |     |                  |
| By:                         |     | /s/ Dan Nir      |
| Name:                       |     | Dan Nir          |
| Title:                      |     | Managing Partner |
| Number of Shares: 61,223.00 |     |                  |

E-19

TABLE OF CONTENTS

Annex F March 13, 2025 Board of Directors Channel Therapeutics Corporation 4400 Route 9 South, Suite 1000 Freehold, NJ 07728 Members of the Board: We understand that Channel Therapeutics Corporation, a publicly traded company (“ CHRO” or the “ Company”), proposes to enter into an Agreement and Plan of Merger (the “ Agreement”), among CHRO, CHRO Merger Sub (“Merger Sub”), and LNHC, Inc., a Delaware corporation (“ Merger Partner”) and pursuant to which, among other things, Merger Sub will merge with and into Merger Partner (the “ Merger”) in accordance